Ge Shen

622 total citations
32 papers, 356 citations indexed

About

Ge Shen is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Ge Shen has authored 32 papers receiving a total of 356 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Epidemiology, 23 papers in Hepatology and 5 papers in Infectious Diseases. Recurrent topics in Ge Shen's work include Hepatitis B Virus Studies (23 papers), Hepatitis C virus research (21 papers) and Liver Disease Diagnosis and Treatment (15 papers). Ge Shen is often cited by papers focused on Hepatitis B Virus Studies (23 papers), Hepatitis C virus research (21 papers) and Liver Disease Diagnosis and Treatment (15 papers). Ge Shen collaborates with scholars based in China and United States. Ge Shen's co-authors include Yao Lu, Lu Zhang, Minghui Li, Leiping Hu, Min Chang, Shuling Wu, Ruyu Liu, Yan Hu, Pan Zhu and Hongxiao Hao and has published in prestigious journals such as Journal of Materials Chemistry, Frontiers in Immunology and Medicine.

In The Last Decade

Ge Shen

29 papers receiving 353 citations

Peers

Countries citing papers authored by Ge Shen

Since Specialization

Citations

This map shows the geographic impact of Ge Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ge Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ge Shen more than expected).

Fields of papers citing papers by Ge Shen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ge Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ge Shen. The network helps show where Ge Shen may publish in the future.

Co-authorship network of co-authors of Ge Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Ge Shen. A scholar is included among the top collaborators of Ge Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ge Shen. Ge Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Association of Cytokines with Clinical Indicators in Patients with Drug-Induced Liver Injury. 2024 ·PubMed ·Wei Cao, Ting Jiang, Ge Shen, Wen Deng, (unknown), (unknown), (unknown), Yao Lu, Lu Zhang, (unknown), Min Chang, (unknown), Yuan Gao, (unknown), (unknown), (unknown), Meng Xu, (unknown), (unknown), Minghui Li	0
2	Hepatitis B core-related antigen serum levels may be a predictor of acute flare of chronic hepatitis B among pregnant women in the immune-tolerant phase of chronic HBV infection after short-course antiviral therapy 2023 ·Virulence ·Ruyu Liu, Yang Liu, Tingting Jiang, Yao Lu, Lu Zhang, Ge Shen, Shuling Wu, Min Chang, Hongxiao Hao, Leiping Hu, Yuanjiao Gao, Mengjiao Xu, Xiaoxue Chen, Wei Yi, Minghui Li, Yao Xie	2
3	Expression of Functional Molecule on Plasmacytoid Dendritic Cells Is Associated With HBsAg Loss in HBeAg-Positive Patients During PEG-IFN α-2a Treatment 2022 ·Frontiers in Immunology ·Weihua Cao, (unknown), Lu Zhang, Xiaoyue Bi, Yanjie Lin, Yang Liu, Yao Lu, Ruyu Liu, Min Chang, Shuling Wu, Ge Shen, Jianping Dong, (unknown), Minghui Li	5
4	Dynamic changes of cytokine profiles and virological markers during 48 weeks of entecavir treatment for HBeAg-positive chronic hepatitis B 2022 ·Frontiers in Immunology ·Minghui Li, Yuanjiao Gao, Yang Liu, Yanjie Lin, Wen Deng, Tingting Jiang, Xiaoyue Bi, Yao Lu, Lu Zhang, Ge Shen, Ruyu Liu, Shuling Wu, Min Chang, Mengjiao Xu, Leiping Hu, Rui Song, Yuyong Jiang, Wei Yi, Yao Xie	4
5	Immune Mechanisms Underlying Hepatitis B Surface Antigen Seroclearance in Chronic Hepatitis B Patients With Viral Coinfection 2022 ·Frontiers in Immunology ·Shuling Wu, Wei Yi, Yuanjiao Gao, Wen Deng, Xiaoyue Bi, Yanjie Lin, Yang Liu, Yao Lu, Ruyu Liu, Min Chang, Ge Shen, Leiping Hu, Lu Zhang, Minghui Li, (unknown)	12
6	Dynamic Changes of Cytokine Profiles and Virological Markers Associated With HBsAg Loss During Peginterferon Alpha-2a Treatment in HBeAg-Positive Chronic Hepatitis B Patients 2022 ·Frontiers in Immunology ·Minghui Li, (unknown), (unknown), Fangfang Sun, Zhan Zeng, Wen Deng, Tingting Jiang, Xiaoyue Bi, Yanjie Lin, Yang Liu, Yao Lu, Ge Shen, Ruyu Liu, Shuling Wu, Min Chang, Leiping Hu, Jianping Dong, Wei Yi, Yao Xie	10
7	The Characteristics of Natural Killer Cells in Chronic Hepatitis B Patients Who Received PEGylated‐Interferon versus Entecavir Therapy 2021 ·BioMed Research International ·Weihua Cao, Minghui Li, Lu Zhang, Yao Lu, Shuling Wu, Ge Shen, Min Chang, Ruyu Liu, Yuanjiao Gao, Hongxiao Hao, Leiping Hu, Wei Yi, Calvin Q. Pan, (unknown)	8
8	Changes of serum IL‐10, IL‐1β, IL‐6, MCP‐1, TNF‐α, IP‐10 and IL‐4 in COVID‐19 patients 2021 ·International Journal of Clinical Practice ·Qingqing Lu, Zhenhua Zhu, Chaochao Tan, Hui Zhou, Yan Hu, Ge Shen, Pan Zhu, Gang Yang, (unknown)	57
9	Outcome of Chinese patients with hepatitis B at 96 weeks after functional cure with IFN versus combination regimens 2021 ·Liver International ·Calvin Q. Pan, Minghui Li, Wei Yi, Lu Zhang, Yao Lu, Hongxiao Hao, Gang Wan, Weihua Cao, (unknown), (unknown), Ge Shen, (unknown), Min Chang, Yuanjiao Gao, Yao Xie	23
10	Roles of 2 SARS-CoV-2 antibody assays in the diagnosis of corona virus disease 2019 2020 ·Laboratory Medicine ·Yan Hu, Ge Shen, Qiong Li, (unknown), (unknown), (unknown), Ping Li, Yufeng Chen, Zhen Zhang, (unknown)	0
11	The reduction in CD8+PD-1+ T cells in liver histological tissue is related to Pegylated IFN-α therapy outcomes in chronic hepatitis B patients 2020 ·BMC Infectious Diseases ·Ruyu Liu, Yanhui Chen, Jiang Guo, Minghui Li, Yao Lu, Lu Zhang, Ge Shen, Shuling Wu, Min Chang, Leiping Hu, Hongxiao Hao, Henghui Zhang, Yao Xie	7
12	Changes in APRI and FIB-4 in HBeAg-negative treatment-naive chronic hepatitis B patients with significant liver histological lesions receiving 5-year entecavir therapy 2019 ·Clinical and Experimental Medicine ·Ruyu Liu, Jiang Guo, Yao Lu, Lu Zhang, Ge Shen, Shuling Wu, (unknown), Leiping Hu, Hongxiao Hao, Minghui Li, Yao Xie	14
13	Quantitation of Plasmacytoid Dendritic Cells in Chronic Hepatitis B Patients with HBeAg Positivity During PEG-IFN and Entecavir Therapy 2018 ·Journal of Interferon & Cytokine Research ·Weihua Cao, Minghui Li, Calvin Q. Pan, Yao Lu, Lu Zhang, (unknown), Shuling Wu, Wenhao Hua, (unknown), Ge Shen, Min Chang, Ruyu Liu, Hongxiao Hao, Leiping Hu, Yao Xie	13
14	Association of Cytokines with Alanine Aminotransferase, Hepatitis B Virus Surface Antigen and Hepatitis B Envelope Antigen Levels in Chronic Hepatitis B 2018 ·Chinese Medical Journal ·Minghui Li, Yao Lu, Lu Zhang, Xingyue Wang, (unknown), Hongxiao Hao, Dan Zhang, (unknown), Ge Shen, Shuling Wu, Weihua Cao, (unknown), Ruyu Liu, Leiping Hu, Min Chang, Wenhao Hua, (unknown), Gang Wan, (unknown)	12
15	Plasmacytoid Dendritic Cell Function and Cytokine Network Profiles in Patients with Acute or Chronic Hepatitis B Virus Infection 2018 ·Chinese Medical Journal ·Minghui Li, Lu Zhang, Dan Zhang, Weihua Cao, (unknown), Hongxiao Hao, Xingyue Wang, (unknown), (unknown), (unknown), Yao Lu, Ge Shen, Shuling Wu, Min Chang, Ruyu Liu, Leiping Hu, Wenhao Hua, Gang Wan, Jun Cheng, (unknown)	11
16	Ratios of T-helper 2 Cells to T-helper 1 Cells and Cytokine Levels in Patients with Hepatitis B 2017 ·Chinese Medical Journal ·Minghui Li, Dan Zhang, Lu Zhang, (unknown), Yao Lu, Ge Shen, Shuling Wu, Min Chang, Ruyu Liu, Leiping Hu, Hongxiao Hao, Wenhao Hua, Shujing Song, Gang Wan, (unknown), (unknown)	11
17	Negative Correlation of Serum Hepatitis B Surface Antigen and Hepatitis B e Antigen Levels with the Severity of Liver Inflammation in Treatment-naïve Patients with Chronic Hepatitis B Virus Infection 2017 ·Chinese Medical Journal ·Lu Zhang, Minghui Li, Weihua Cao, (unknown), Yao Lu, Shuling Wu, Hongxiao Hao, Ge Shen, Ruyu Liu, Leiping Hu, Min Chang, Wenhao Hua, Shujing Song, Gang Wan, Yao Xie	9
18	Kinetics of Hepatitis B Surface Antigen Level in Chronic Hepatitis B Patients who Achieved Hepatitis B Surface Antigen Loss during Pegylated Interferon Alpha-2a Treatment 2017 ·Chinese Medical Journal ·Minghui Li, Lu Zhang, (unknown), Yao Lu, Ge Shen, Shuling Wu, Min Chang, Ruyu Liu, Leiping Hu, Zhenzhen Li, Wenhao Hua, Shujing Song, (unknown)	17
19	Hepatitis B surface antigen clearance in inactive hepatitis B surface antigen carriers treated with peginterferon alfa-2a 2016 ·World Journal of Hepatology ·Minghui Li, (unknown), Lu Zhang, Yao Lu, Ge Shen, Shuling Wu, Min Chang, (unknown), Leiping Hu, Wenhao Hua, Shujing Song, Shufeng Zhang, Jun Cheng, (unknown)	23
20	[Study on the etiology of acute hepatitis hospitalized patients in Beijing Ditan Hospital from 2002 to 2011]. 2013 ·PubMed ·Ge Shen, Lu Zhang, (unknown), Leiping Hu, Minghui Li, Yao Lu, Xinghong Li, Guo‐Hua Qiu, Liwei Zhuang, (unknown), Hui Zhao, Lijun Chen, Min Yang, (unknown), Yao Xie, Jun Cheng, (unknown)	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact